Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ÌìÃÀ´«Ã½ Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Deep brain stimulation (DBS) is a circuit-based treatment shown to relieve symptoms from multiple neurologic and neuropsychiatric
disorders. In order to treat the memory deficit associated with Alzheimer�s disease (AD), several clinical trials have tested the
efficacy of DBS near the fornix. Early results from these studies indicated that patients that received fornix DBS experienced an
improvement in memory and quality of life, yet the mechanisms behind this effect remain controversial. It is known that transmission
between the medial limbic and corticolimbic circuits plays an integral role in declarative memory and dysfunction at the circuit level
results in various forms of dementia, including AD. Here, we aimed to determine the potential underlying mechanism of fornix DBS
by examining the functional circuitry and structures of the brain engaged by fornix DBS. A multimodal approach was employed to
examine global and local temporal changes that occur in an anesthetized swine model of fornix DBS. Changes in global functional
activity were measured by functional MRI (fMRI) and local neurochemical changes were monitored by fast scan cyclic voltammetry
(FSCV) during electrical stimulation of the fornix. Additionally, intracranial microinfusions into the nucleus accumbens (NAc)
were performed to investigate the global activity changes that occur with dopamine and glutamate receptor-specific antagonism.
Hemodynamic responses in both medial limbic and corticolimbic circuits measured by fMRI were induced by fornix DBS. Additionally,
fornix DBS resulted in increases in dopamine oxidation current (corresponding to dopamine efflux) monitored by FSCV in the
NAc. Finally, fornix DBS-evoked hemodynamic responses in the amygdala and hippocampus decreased following dopamine and
glutamate receptor antagonism in the NAc. The present findings suggest that fornix DBS modulates dopamine release on pre-synaptic
dopaminergic terminals in the NAc, involving excitatory glutamatergic input and that the medial limbic and corticolimbic circuits
interact in a functional loop.